Shares of Kilitch Drugs (India) Limited, engaged in the development and operations of pharmaceutical products, surged 14.2% to ₹344 on Wednesday, after reporting Q2FY25 results with a significant rise in the net profit by nearly 7718.2% QoQ and 69% YoY. Further, the company’s revenue from operations also increased by about 42% QoQ and 15.3% YoY.